Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The United States Department of Veterans Affairs has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The portfolio shows a narrow distribution of work across 1 distinct examiner and 1 distinct art unit. This concentration suggests that the department's current prosecution efforts are localized within a specific technical niche and handled by a single point of contact at the office. The presence of only 1 distinct art unit indicates a focused subject matter for the current filings, which may lead to a more consistent examination experience.
MYERS, CARLA J is identified as the busiest examiner, currently handling 1 pending office action. This single action constitutes the total pending volume for the company at this time. With 1 distinct examiner managing the workload, the prosecution process remains highly centralized. The department's activity within the Biotechnology & Pharmaceuticals sector is currently limited to this specific interaction, as evidenced by the 1 pending office action and the involvement of only 1 distinct examiner. This streamlined approach minimizes the administrative complexity of managing multiple pending applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MYERS, CARLA J | 1 | 49.5% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18388985 | COMPOSITIONS AND METHODS FOR CHARACTERIZING BLADDER CANCER | MYERS, CARLA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18388985 | COMPOSITIONS AND METHODS FOR CHARACTERIZING BLADDER CANCER | MYERS, CARLA J | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18388985 | COMPOSITIONS AND METHODS FOR CHARACTERIZING BLADDER CANCER | MYERS, CARLA J | 1682 | §101§103§112 | Non-Final OA | — | Pending | Nov 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe United States Department of Veterans Affairs has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Carla J Myers has the most, with 1 of The United States Department of Veterans Affairs's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
